Mannkind MNKD Onbody Infusor — Intangible Amortization
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Mannkind in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.
The official record: Mannkind’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mannkind's onbody infusor — intangible amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mannkind's onbody infusor — intangible amortization?
- Mannkind (MNKD) reported onbody infusor — intangible amortization of $4.3M in Q1 2026.
- How has Mannkind's onbody infusor — intangible amortization changed year-over-year?
- Mannkind's onbody infusor — intangible amortization increased by 330.0% year-over-year, from $1M to $4.3M.
- What does onbody infusor — intangible amortization mean?
- This represents the periodic non-cash expense recognized during the reporting period to allocate the cost of the Onbody Infusor segment's finite-lived intangible assets over their useful lives. It reflects the systematic consumption of the economic benefits derived from these specific assets. This metric is essential for understanding the impact of intangible asset depreciation on the segment's reported operating profitability.